期刊文献+

VEGF基因多态性与糖尿病视网膜病变相关性的研究进展 被引量:4

Research advances on correlation between polymorphism of VEGF gene and diabetic retinopathy
下载PDF
导出
摘要 糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病常见的微血管并发症之一,是糖尿病微血管病变和神经病变在视网膜微血管环境中的表现,已经成为世界上成年人致盲的主要原因之一。近年来,DR的发病率和致盲率逐年增加,严重影响患者的生存质量。DR的发病机制与多种因素有关,涉及基因多态性、细胞因子、生化机制及炎症作用等,其中VEGF基因多态性成为近年来研究DR发病机制的热点之一。目前发现VEGF基因-634G/C、+405G/C、-2578C/A、936C/T、460C/T等与DR的发生发展具有一定的相关性。但对VEGF基因多态性与DR相关性的研究结果尚无统一的认识。本文就目前DR与VEGF基因多态性的相关研究进展进行综述。 Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes mellitus. It is manifestation of diabetic microvascular patho- logical change and neuropathy in retinal microvascular environment, and is now one of the main causes of adult blinding in the world. The gradually rising morbidity and blind- ing rate of DR are exerting a serious influence on living quality of patients. DR patho- genesis is associated with many factors, including gene polymorphism, cytokines, bio- chemical mechanism and inflammation, of which polymorphism of VEGF gene has be- come a hotspot of researches for DR pathogenesis in recent years. According to present findings,certain correlations exist between VEGF genes such as -634G/C, + 405G/C, -2578C/A,935C/T,450C/T and DR pathogenesis. Yet there is no common understand- ing about research outcome of correlational study between polymorphism of VEGF gene and DR. This article is to review research advances on correlation between polymor- phism of VEGF gene and DR.
出处 《眼科新进展》 CAS 北大核心 2013年第9期883-886,共4页 Recent Advances in Ophthalmology
基金 国家重点基础研究发展计划(973计划)(编号:2013CB967001) 国家自然科学基金(编号:31271400) 河南省基础与前沿技术研究计划(编号:122300410334)~~
关键词 糖尿病视网膜病变 血管内皮生长因子 基因多态性 diabetic retinopathy vascular endothelial growth factor gene poly-morphism
  • 相关文献

参考文献30

  • 1Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 [ J]. Diabetes Care ,2004,27 ( 5 ) : 1047-1053. 被引量:1
  • 2Lam DW,LeRoith D. The worldwide diabetes epidemic[J]. Curt Opin Endocrino Diabetes Obes ,2012,19 ( 2 ) :93-95. 被引量:1
  • 3Liu L, Wu X, Liu L, Geng J, Yuan Z, Shah Z, et al. Prevalence of diabetic retinopathy in China's Mainland: a meta-analysis [ J]. PloS One,2012,7 (9) : e45264. 被引量:1
  • 4Ferrara N. Vascular endothelial growth factor:basic science and clinical progress [J]. Endocr Rev, 2004,25 ( 4 ) : 581-611. 被引量:1
  • 5Treins C, Giorgetti-Peraldi S, Murdaca J, Van Obberghen E. Reg- ulation of vascular endothelial growth factor expression by ad- vanced glycation end products [ J ]. J Biol Chem, 2001,276 (47) : 43836-43841. 被引量:1
  • 6Tamarat R, Silvestre JS, Huijberts M, Benessiano J, Ebrahimian TG, Duriez M, et al. Blockade of advanced glycation end-product formation restores ischemia-induced angiogenesis in diabetic mice[ J]. Pro Natl Acad Sci USA ,2003,100(14) :8555-8550. 被引量:1
  • 7Gupta N Mansoor S, Sharma A, Sapkal A, Sheth J, Falatoonza- deh P,et al. Diabetic retinopathy and VEGF[ ]. Open Ophthal- mol J,2013,7( 1 ) :4-10. 被引量:1
  • 8Tischer E, Mitchell R, Hartman T, Silva M, Gospodarowicz D, Fiddes JC, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alter- native exon splicing [ J]. J Biol Chem, 1991,256 ( 18 ) : 11947- 11954. 被引量:1
  • 9Pages G, Pouyssegur J. Transcriptional regulation of the vascu- lar endothelial growth factor gene--a concert of activating fac- tors [ J ]. Cardiovasc Res ,2005 ,55 ( 3 ) :554-573. 被引量:1
  • 10Jain L, Vargo CA, Danesi R, Sissung TM, Price DK, Venzon D, et al. The role of vascular endothelial growth factor SNPs as pre- dictive and prognostic markers for major solid tumors [J].Mol Cancer Ther,2009,8 (9) :2495-2508. 被引量:1

同被引文献65

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部